# Olema Pharmaceuticals, Inc.: filings

OLMA · Nasdaq · CIK 1750284 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/olma.md) · [Financials](/companies/olma/financials.md) · [Filings](/companies/olma/filings.md) · [Insiders](/companies/olma/insiders.md)

## Reports and events: 106 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 203, 144 97, 8-K 65, 3 26, SC 13G/A 20, 10-Q 17, 4/A 14, SC 13G 14, SCHEDULE 13G/A 12, CORRESP 7, S-8 7, 10-K 6, DEF 14A 6, DEFA14A 6, UPLOAD 6, 424B5 5, D 5, EFFECT 5, SC 13D/A 5, ARS 4, S-3 4, SCHEDULE 13G 3, 424B3 2, DRSLTR 2, SC 13D 2, SCHEDULE 13D/A 2, SEC STAFF LETTER 2, 3/A 1, 424B4 1, 8-A12B 1, 8-K/A 1, CERT 1, D/A 1, DEL AM 1, DRS 1, DRS/A 1, S-1 1, S-1/A 1, S-1MEF 1, S-3ASR 1, S-3MEF 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-16 | 21:58 ET | [SCHEDULE 13D/A](/filings/0000921895-26-002806.md) | Ownership report, active investor, amended | 0000921895-26-002806 |
| 2026-10-15 | 21:00 ET | [8-K](/filings/0001193125-26-423002.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-423002 |
| 2026-08-13 | 11:05 ET | [8-K](/filings/0001193125-26-347853.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-347853 |
| 2026-08-10 | 20:10 ET | [10-Q](/filings/0001193125-26-342383.md) | Quarterly report, period 2026-06-30 | 0001193125-26-342383 |
| 2026-08-10 | 20:05 ET | [8-K](/filings/0001193125-26-342334.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-342334 |
| 2026-06-23 | 20:19 ET | [8-K](/filings/0001193125-26-279483.md) | 5.07 Shareholder vote results | 0001193125-26-279483 |
| 2026-05-26 | 11:05 ET | [8-K](/filings/0001193125-26-237832.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-237832 |
| 2026-05-21 | 21:05 ET | [8-K](/filings/0001193125-26-234848.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-234848 |
| 2026-05-12 | 11:10 ET | [10-Q](/filings/0001193125-26-218156.md) | Quarterly report, period 2026-03-31 | 0001193125-26-218156 |
| 2026-05-12 | 11:05 ET | [8-K](/filings/0001193125-26-218142.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-218142 |
| 2026-05-01 | 21:27 ET | [8-K](/filings/0001193125-26-201751.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation | 0001193125-26-201751 |
| 2026-04-29 | 20:36 ET | [DEF 14A](/filings/0001193125-26-191956.md) | Proxy statement, period 2026-04-29 | 0001193125-26-191956 |
| 2026-04-29 | 20:34 ET | [8-K](/filings/0001193125-26-191944.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-191944 |
| 2026-03-16 | 11:10 ET | [10-K](/filings/0001193125-26-107169.md) | Annual report, period 2025-12-31 | 0001193125-26-107169 |
| 2026-03-16 | 11:05 ET | [8-K](/filings/0001193125-26-107154.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-107154 |
| 2026-01-30 | 21:07 ET | [8-K](/filings/0001193125-26-031792.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-031792 |
| 2026-01-12 | 21:44 ET | [8-K](/filings/0001193125-26-010507.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-010507 |
| 2025-11-19 | 22:20 ET | [8-K](/filings/0001193125-25-288343.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-288343 |
| 2025-11-18 | 21:23 ET | [8-K](/filings/0001193125-25-286206.md) | 8.01 Other events | 0001193125-25-286206 |
| 2025-11-10 | 12:10 ET | [10-Q](/filings/0001193125-25-273236.md) | Quarterly report, period 2025-09-30 | 0001193125-25-273236 |
| 2025-11-10 | 12:05 ET | [8-K](/filings/0001193125-25-273228.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-273228 |
| 2025-10-20 | 21:13 ET | [8-K](/filings/0001193125-25-243765.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-243765 |
| 2025-09-02 | 11:05 ET | [8-K](/filings/0001750284-25-000007.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001750284-25-000007 |
| 2025-08-11 | 20:15 ET | [10-Q](/filings/0000950170-25-106565.md) | Quarterly report, period 2025-06-30 | 0000950170-25-106565 |
| 2025-08-11 | 20:08 ET | [8-K](/filings/0000950170-25-106545.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-106545 |
| 2025-06-13 | 20:30 ET | [8-K](/filings/0000950170-25-086256.md) | 5.07 Shareholder vote results | 0000950170-25-086256 |
| 2025-05-13 | 23:29 ET | [SCHEDULE 13D/A](/filings/0000935836-25-000324.md) | Ownership report, active investor, amended | 0000935836-25-000324 |
| 2025-05-13 | 20:15 ET | [10-Q](/filings/0000950170-25-070374.md) | Quarterly report, period 2025-03-31 | 0000950170-25-070374 |
| 2025-05-13 | 20:05 ET | [8-K](/filings/0000950170-25-070291.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-070291 |
| 2025-04-28 | 20:30 ET | [DEF 14A](/filings/0000950170-25-059348.md) | Proxy statement, period 2025-04-28 | 0000950170-25-059348 |
| 2025-03-18 | 20:15 ET | [10-K](/filings/0000950170-25-041204.md) | Annual report, period 2024-12-31 | 0000950170-25-041204 |
| 2025-03-18 | 20:10 ET | [8-K](/filings/0000950170-25-041186.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-041186 |
| 2025-03-05 | 12:15 ET | [8-K](/filings/0000950170-25-033073.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-033073 |
| 2025-01-13 | 12:15 ET | [8-K](/filings/0000950170-25-004563.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-004563 |
| 2025-01-10 | 21:01 ET | [8-K](/filings/0001193125-25-004427.md) | 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-25-004427 |
| 2024-12-10 | 12:15 ET | [8-K](/filings/0000950170-24-134759.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-134759 |
| 2024-12-04 | 00:49 ET | [SC 13D/A](/filings/0000921895-24-002885.md) | Ownership report, active investor, amended | 0000921895-24-002885 |
| 2024-12-02 | 12:15 ET | [8-K](/filings/0000950170-24-131965.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-131965 |
| 2024-11-12 | 21:15 ET | [10-Q](/filings/0000950170-24-125427.md) | Quarterly report, period 2024-09-30 | 0000950170-24-125427 |
| 2024-11-12 | 21:10 ET | [8-K](/filings/0000950170-24-125384.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-125384 |
| 2024-09-27 | 11:00 ET | [8-K](/filings/0000950170-24-109753.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-109753 |
| 2024-08-06 | 20:15 ET | [10-Q](/filings/0000950170-24-091836.md) | Quarterly report, period 2024-06-30 | 0000950170-24-091836 |
| 2024-08-06 | 20:10 ET | [8-K](/filings/0000950170-24-091799.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-091799 |
| 2024-07-02 | 20:30 ET | [8-K](/filings/0000950170-24-080546.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation | 0000950170-24-080546 |
| 2024-06-14 | 20:39 ET | [8-K](/filings/0000950170-24-073749.md) | 5.07 Shareholder vote results | 0000950170-24-073749 |
| 2024-06-06 | 22:49 ET | [SC 13D/A](/filings/0000935836-24-000426.md) | Ownership report, active investor, amended | 0000935836-24-000426 |
| 2024-05-15 | 11:06 ET | [8-K](/filings/0000950170-24-060031.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-060031 |
| 2024-05-08 | 20:15 ET | [10-Q](/filings/0000950170-24-055686.md) | Quarterly report, period 2024-03-31 | 0000950170-24-055686 |
| 2024-05-08 | 20:06 ET | [8-K](/filings/0000950170-24-055630.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-055630 |
| 2024-04-26 | 21:07 ET | [DEF 14A](/filings/0000950170-24-049287.md) | Proxy statement, period 2023-12-31 | 0000950170-24-049287 |

Page 1 of 3. [Older](/companies/olma/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.